1. Home
  2. GDC vs NTHI Comparison

GDC vs NTHI Comparison

Compare GDC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

HOLD

Current Price

$3.11

Market Cap

241.3M

Sector

Industrials

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$10.36

Market Cap

243.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDC
NTHI
Founded
2015
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.3M
243.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GDC
NTHI
Price
$3.11
$10.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.4K
69.4K
Earning Date
03-17-2026
02-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.42
N/A
Revenue
N/A
$59,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.03
$3.20
52 Week High
$9.92
$25.00

Technical Indicators

Market Signals
Indicator
GDC
NTHI
Relative Strength Index (RSI) 33.15 57.79
Support Level $3.10 $9.05
Resistance Level $3.78 $11.38
Average True Range (ATR) 0.37 1.16
MACD -0.09 0.11
Stochastic Oscillator 0.63 57.54

Price Performance

Historical Comparison
GDC
NTHI

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: